Treating cancer with selective CDK4/6 inhibitors. (2016)
Attributed to:
MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/nrclinonc.2016.26
PubMed Identifier: 27030077
Publication URI: http://europepmc.org/abstract/MED/27030077
Type: Journal Article/Review
Volume: 13
Parent Publication: Nature reviews. Clinical oncology
Issue: 7
ISSN: 1759-4774